Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Curaleaf Holdings (CURLF) Cash & Equivalents (2021 - 2025)

Curaleaf Holdings (CURLF) has 5 years of Cash & Equivalents data on record, last reported at $101.6 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 5.27% year-over-year to $101.6 million; the TTM value through Dec 2025 reached $101.6 million, down 5.27%, while the annual FY2025 figure was $101.6 million, 5.27% down from the prior year.
  • Cash & Equivalents reached $101.6 million in Q4 2025 per CURLF's latest filing, down from $107.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $299.3 million in Q4 2021 and bottomed at $91.8 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $152.6 million, with a median of $107.2 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 45.49% in 2022, then rose 16.78% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $299.3 million in 2021, then plummeted by 45.49% to $163.2 million in 2022, then tumbled by 43.73% to $91.8 million in 2023, then rose by 16.78% to $107.2 million in 2024, then dropped by 5.27% to $101.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $101.6 million in Q4 2025, $107.2 million in Q4 2024, and $91.8 million in Q4 2023.